BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24735964)

  • 1. SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.
    Niswander LM; Fegan KH; Kingsley PD; McGrath KE; Palis J
    Blood; 2014 Jul; 124(2):277-86. PubMed ID: 24735964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDF-1 directs megakaryocyte relocation.
    Thon JN
    Blood; 2014 Jul; 124(2):161-3. PubMed ID: 25013161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoiesis is spatially regulated by the bone marrow vasculature.
    Stegner D; vanEeuwijk JMM; Angay O; Gorelashvili MG; Semeniak D; Pinnecker J; Schmithausen P; Meyer I; Friedrich M; Dütting S; Brede C; Beilhack A; Schulze H; Nieswandt B; Heinze KG
    Nat Commun; 2017 Jul; 8(1):127. PubMed ID: 28743899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation.
    Hamada T; Möhle R; Hesselgesser J; Hoxie J; Nachman RL; Moore MA; Rafii S
    J Exp Med; 1998 Aug; 188(3):539-48. PubMed ID: 9687531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
    Avecilla ST; Hattori K; Heissig B; Tejada R; Liao F; Shido K; Jin DK; Dias S; Zhang F; Hartman TE; Hackett NR; Crystal RG; Witte L; Hicklin DJ; Bohlen P; Eaton D; Lyden D; de Sauvage F; Rafii S
    Nat Med; 2004 Jan; 10(1):64-71. PubMed ID: 14702636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK).
    Hodohara K; Fujii N; Yamamoto N; Kaushansky K
    Blood; 2000 Feb; 95(3):769-75. PubMed ID: 10648384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting PGE2 and Lisinopril Mitigate H-ARS.
    Saunders J; Niswander LM; McGrath KE; Koniski A; Catherman SC; Ture SK; Medhora M; Kingsley PD; Calvi LM; Williams JP; Morrell CN; Palis J
    Radiat Res; 2021 Sep; 196(3):284-296. PubMed ID: 34153091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
    Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
    PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.
    Abraham M; Weiss ID; Wald H; Wald O; Nagler A; Beider K; Eizenberg O; Peled A
    Br J Haematol; 2013 Oct; 163(2):248-59. PubMed ID: 23906028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2-inositol phosphatase 1 negatively influences early megakaryocyte progenitors.
    Perez LE; Desponts C; Parquet N; Kerr WG
    PLoS One; 2008; 3(10):e3565. PubMed ID: 18958162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction induces bone marrow megakaryocyte proliferation, maturation and platelet production.
    Fu W; Wang J; Jiang H; Hu X
    Biochem Biophys Res Commun; 2019 Mar; 510(3):456-461. PubMed ID: 30732856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice.
    Dhanjal TS; Pendaries C; Ross EA; Larson MK; Protty MB; Buckley CD; Watson SP
    Blood; 2007 May; 109(10):4237-44. PubMed ID: 17234740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.
    Lane WJ; Dias S; Hattori K; Heissig B; Choy M; Rabbany SY; Wood J; Moore MA; Rafii S
    Blood; 2000 Dec; 96(13):4152-9. PubMed ID: 11110686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGFR1 stimulates a CXCR4-dependent translocation of megakaryocytes to the vascular niche, enhancing platelet production in mice.
    Pitchford SC; Lodie T; Rankin SM
    Blood; 2012 Oct; 120(14):2787-95. PubMed ID: 22653973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation.
    Mazharian A; Ghevaert C; Zhang L; Massberg S; Watson SP
    Blood; 2011 May; 117(19):5198-206. PubMed ID: 21385851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody against integrin α
    Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
    J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.
    Mazharian A; Watson SP; Séverin S
    Exp Hematol; 2009 Oct; 37(10):1238-1249.e5. PubMed ID: 19619605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
    Fock EL; Yan F; Pan S; Chong BH
    Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis.
    Gomes AL; Carvalho T; Serpa J; Torre C; Dias S
    Blood; 2010 May; 115(19):3886-94. PubMed ID: 20009035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.